Sio Capital Management, LLC Glycomimetics Inc Put Options Transaction History

Sio Capital Management, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $308,280 - $1.41 Million	-110,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.6 - $13.12 $1.17 Million - $1.44 Million	110,100 New	110,100 $1.31 Million

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.